A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference30 articles.
1. Collaborative meta-analysis of randomized clinical trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients;Antithrombotic Trialist' Collaboration;Br. Med. J.,2002
2. Cycloxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E-deficient and Low-density lipoprotein receptor-null mice;Babaev;Circulation,2006
3. Cyclo-oxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis;Belton;Circulation,2000
4. Cyclo-oxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis;Belton;Circulation,2003
5. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apoE-deficient mice. Evidence that eicosanoids other than thromboxane contribute to atherosclerosis;Cayatte;Arterioscler. Thromb. Vasc. Biol.,2000
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The association between thromboxane A2 receptor gene polymorphisms and the risk of cerebral infarction;Clinical Neurology and Neurosurgery;2020-11
2. Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis;PLOS ONE;2016-03-28
3. Could the thromboxane A2 pathway be a therapeutic target for the treatment of obstructive sleep apnea-induced atherosclerosis?;Prostaglandins & Other Lipid Mediators;2015-09
4. Prostanoids, Their Receptors, and Atherogenesis;Atherosclerosis;2015-03-27
5. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells;Biochemical and Biophysical Research Communications;2013-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3